Browse by author
Lookup NU author(s): Dr Kathryn Musgrave
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2022. Cancer-associated thrombosis (CAT) is a leading cause of death amongst people with cancer. Treatment decisions have become increasingly complex with the introduction of direct oral anticoagulants and existing guidelines are limited to evidence from patients meeting stringent trial-entry criteria. To assist decision making for healthcare professionals managing CAT in challenging ‘real-world’ situations, an expert working group of clinicians from oncology, haematology and pharmacology convened over a series of virtual meetings between September 2020 and January 2021 to catalogue the most challenging clinical problems and define consensus recommendations. Clinical problems were divided amongst the group members according to their areas of expertise, with each reviewing the literature and writing their recommendations. Using a web-based file-sharing platform, each contribution was reviewed until consensus was reached. Each clinical problem is discussed; these include managing gastrointestinal impairment, renal impairment, liver impairment, increased risk of bleeding, extremes of body weight, drug interactions, anticoagulation beyond the initial six months and managing recurrent thrombosis. A user-friendly, practical, colour-coded algorithm was produced to help guide clinical decision-making in CAT. Red highlights decision steps where shared decision making, such as with the multi-disciplinary team, is recommended. Amber steps reflect uncertainty of existing evidence. Multiple amber steps per patient warrant increased caution. Making anticoagulation decisions in people with cancer is challenging; it is important that healthcare providers can discuss where there is a lack of evidence and ensure that patient preference is given priority. This algorithm and consensus recommendations are a useful tool to guide these complex discussions.
Author(s): Musgrave KM, Power K, Laffan M, O'Donnell JS, Thachil J, Maraveyas A
Publication type: Review
Publication status: Published
Journal: Critical Reviews in Oncology/Hematology
Year: 2022
Volume: 171
Print publication date: 01/03/2022
Online publication date: 19/01/2022
Acceptance date: 17/01/2022
ISSN (print): 1040-8428
ISSN (electronic): 1879-0461
Publisher: Elsevier Ireland Ltd
URL: https://doi.org/10.1016/j.critrevonc.2022.103599
DOI: 10.1016/j.critrevonc.2022.103599
PubMed id: 35065219
